Annual Current Ratio
5.35
-1.62-23.24%
31 December 2023
Summary:
Lyra Therapeutics annual current ratio is currently 5.35, with the most recent change of -1.62 (-23.24%) on 31 December 2023. During the last 3 years, it has fallen by -10.19 (-65.57%). LYRA annual current ratio is now -65.57% below its all-time high of 15.54, reached on 31 December 2020.LYRA Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
3.64
+0.04+1.11%
30 September 2024
Summary:
Lyra Therapeutics quarterly current ratio is currently 3.64, with the most recent change of +0.04 (+1.11%) on 30 September 2024. Over the past year, it has dropped by -1.81 (-33.21%). LYRA quarterly current ratio is now -83.94% below its all-time high of 22.66, reached on 30 June 2020.LYRA Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYRA Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -33.2% |
| 3 y3 years | -65.6% | +6.1% |
| 5 y5 years | -57.9% | - |
LYRA Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.6% | +103.4% | -70.7% | +59.6% |
| 5 y | 5 years | -65.6% | +175.8% | -83.9% | +87.6% |
| alltime | all time | -65.6% | +175.8% | -83.9% | +87.6% |
Lyra Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 3.64(+1.1%) |
| June 2024 | - | 3.60(-24.7%) |
| Mar 2024 | - | 4.78(-10.7%) |
| Dec 2023 | 5.35(-23.2%) | 5.35(-1.8%) |
| Sept 2023 | - | 5.45(-35.0%) |
| June 2023 | - | 8.38(+39.9%) |
| Mar 2023 | - | 5.99(-14.1%) |
| Dec 2022 | 6.97 | 6.97(-15.5%) |
| Sept 2022 | - | 8.25(-33.5%) |
| June 2022 | - | 12.40(+443.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 2.28(-13.3%) |
| Dec 2021 | 2.63(-83.1%) | 2.63(-23.3%) |
| Sept 2021 | - | 3.43(-71.1%) |
| June 2021 | - | 11.87(-26.5%) |
| Mar 2021 | - | 16.15(+3.9%) |
| Dec 2020 | 15.54(+701.0%) | 15.54(-12.5%) |
| Sept 2020 | - | 17.75(-21.7%) |
| June 2020 | - | 22.66(+228.9%) |
| Mar 2020 | - | 6.89(+255.2%) |
| Dec 2019 | 1.94(-84.7%) | 1.94 |
| Dec 2018 | 12.72 | - |
FAQ
- What is Lyra Therapeutics annual current ratio?
- What is the all time high annual current ratio for Lyra Therapeutics?
- What is Lyra Therapeutics annual current ratio year-on-year change?
- What is Lyra Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly current ratio year-on-year change?
What is Lyra Therapeutics annual current ratio?
The current annual current ratio of LYRA is 5.35
What is the all time high annual current ratio for Lyra Therapeutics?
Lyra Therapeutics all-time high annual current ratio is 15.54
What is Lyra Therapeutics annual current ratio year-on-year change?
Over the past year, LYRA annual current ratio has changed by -1.62 (-23.24%)
What is Lyra Therapeutics quarterly current ratio?
The current quarterly current ratio of LYRA is 3.64
What is the all time high quarterly current ratio for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly current ratio is 22.66
What is Lyra Therapeutics quarterly current ratio year-on-year change?
Over the past year, LYRA quarterly current ratio has changed by -1.81 (-33.21%)